Aster Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 4.67 Cr
as on 11-12-2024
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2014
About Aster Drugs And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.67 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suresh Singla, Davinder Dhaliwal, Amarjit Bhatia, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24232CH1994PLC014434
- Company No.
014434
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Apr 1994
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aster Drugs And Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Singla  | Nominee Director | 22-Mar-2006 | Current |
| Davinder Dhaliwal | Nominee Director | 22-Mar-2006 | Current |
| Amarjit Bhatia | Director | 29-Nov-1996 | Current |
| Umesh Mishra | Director | 23-Oct-2013 | Current |
| Neena Syan | Whole-Time Director | 29-Jun-2007 | Current |
| Inderjit Chopra | Director | 15-Jul-2008 | Current |
Financial Performance and Corporate Structure Insights of Aster Drugs And Pharmaceuticals.
Enhance accessibility to Aster Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aster Drugs And Pharmaceuticals?
Unlock access to Aster Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Mayfair Clinical Education And Research Centre Pvt. Ltd.Active 37 years 5 days
Umesh Mishra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aster Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Aster Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aster Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aster Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
